Article Text

Download PDFPDF

Research Letter
Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi
Free
  1. Yasaman Zia1,2,
  2. Nicole Davis1,
  3. Jeffrey Wiener1,
  4. Marica M Hobbs3,
  5. Dana Lapple3,
  6. Lameck Chinula4,5,
  7. Gerald Tegha5,
  8. Albans Msika5,
  9. Jennifer Tang4,5,
  10. Athena P Kourtis1
  1. 1Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  2. 2Association of Schools and Programs of Public Health, Washington, DC, USA
  3. 3Division of Infectious Disease, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
  4. 4School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
  5. 5UNC Project, Lilongwe, Central Region, Malawi
  1. Correspondence to Ms Yasaman Zia, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA; yaszia{at}gmail.com

Statistics from Altmetric.com

Self-report of sexual behaviours in clinical studies is often subject to misreporting due to recall or social desirability bias or misinterpretation of the study questionnaires.1 Use of biomarkers of semen exposure, such as the detection of prostate-specific antigen (PSA) in vaginal secretions, offers an additional means of assessing sexual behaviours and condom use that is not subject to reporting biases.2 In a secondary analysis of a clinical trial of hormonal contraception in Malawi,3 we examined associations of discordance between PSA detection and self-report of condomless sex over time with participant characteristics using log-binomial regression analyses with generalised estimating equations for repeated measures. All analyses were conducted using SAS V.9.3 (SAS Institute, Cary, North Carolina, USA). Testing for PSA was performed using the ABAcard p30 rapid immunochromatographic strip test (Abacus Diagnostics, West Hills, California, USA); samples containing ≥1.0 ng PSA/mL were considered positive for detection of semen, as previously described.4 Discordance between PSA detection and self-report was defined as detection of PSA in the vaginal samples, with report of condom use at last sex or no sex since last study visit. Given the rapid clearance of PSA, negative results for PSA were not considered in the definition of discordance or concordance, regardless of whether condomless sex was self-reported or not.4

This analysis included 539 vaginal swabs from 97 women. Most women were HIV-positive (75.3%), married (70.1%); 40.2% had not completed primary education; their mean age was 32.5 years and median number of children was three. Fifty-four (55.7%) women reported unprotected sex at least once during the study. At least once during follow-up, 56.7% of women tested positive for PSA. PSA detection was significantly associated with younger age, HIV-negative status, and self-report of sex within 48 hours of a study visit (table 1). Of PSA-positive samples, 62.3% (66/106) were discordant with self-report. HIV-positive status (prevalence ratio (PR): 1.74, 95% CI: 1.19 to 2.54) and non-completion of primary school education (PR: 1.42, 95% CI: 1.12 to 1.78) were associated with such discordance (table 1).

Table 1

Factors associated with vaginal PSA detection and with discordance (between PSA test result and self-report of sexual activity), progestin study, Lilongwe, Malawi

In our study, PSA detection was less prevalent among HIV-positive women than HIV-negative women. However, discordance between PSA test result and self-report of sexual activity was more prevalent among HIV-positive women and women who did not complete primary school education. We were unable to evaluate qualitative or individual reasons for such discordance. Misclassification of sexual exposure and misreported condom use can overestimate or underestimate associations of sexual behaviours with clinical outcomes, such as transmission of HIV, other STIs5 or pregnancy. Incorporating objective biomarkers of sexual exposure in research studies may mitigate the biases of self-report.

References

View Abstract

Footnotes

  • Contributors APK, JT, LC were involved in the planning, conduct and design of the clinical trial. JT, LC, GT, AM collected data and specimens. MMH, DL produced the lab results. YZ, ND, JW performed the statistical analysis. JT, APK, YZ interpreted the data. All authors have contributed to the manuscript and have read and approved the paper.

  • Funding This work was supported by the Centers of Disease Control and Prevention and Association of Schools and Programs of Public Health (6NU36OE000002).

  • Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention, other funding agencies or the US Government. YZ is no longer a CDC affiliate.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.